BEONE MEDICINES LTD

WESPAC Advisors SoCal added a real 3.2% to its BeOne Medicines position this quarter (4,925 to 5,082 shares, +$44,740 in flow terms), yet the position's reported dollar value fell by $14,359 — the stock's price dropped enough to erase the appearance of any buying at all. Crossmark Global Holdings made the quarter's largest genuine addition, growing 40.4% (7,661 to 10,755 shares, +$881,697), while seven new institutions opened positions, led by Peak Financial Advisors ($1.4 million) and Charles Schwab Trust Co ($854,910). Selling was scarce and small: only two holders reported reductions, both under $75,000 in flow terms.